Sustaining Generic Medicines Markets in Europe

More documents

Recommendations

Info

Sustaining generic medicines markets 46from a financial perspective. However, generic substitution by pharmacists is not allowed inpractice. Furthermore, the impact of the guarantee of pharmacists’ absolute margins on thedevelopment of the generic medicines market needs to be analysed in conjunction with the RPS.On the one hand, the reduction in RPs over time translates into decreased public prices ofgeneric medicines. On the other hand, pharmacist margins on generic medicines are guaranteedin absolute terms. This puts pressure on pharmaceutical companies to reduce ex-factory pricelevels and may jeopardise entry and survival of generic medicines.Key factors hindering the development of the generic medicines market:• Successive reductions of the RP and the guarantee of absolute pharmacist margins threatenthe economic viability of the generic medicines market• Physicians have few incentives to prescribe generic medicines• There are no incentives for pharmacists to dispense generic medicinesKey factors aiding the development of the generic medicines market:• Generic medicines use has been stimulated by the introduction of a RPS
Sustaining generic medicines markets 479 France9.1 Generic medicines marketFrance had an undeveloped generic medicines market during the second half of the 1990s. Thischanged with the introduction of incentives for physicians and pharmacists in the early 2000s.Market share of generic medicines has grown from 0.9% in 1994 to 6.6% in 2004 in terms ofvalue of consumption and from 1.8% in 1994 to 10.4% in 2004 in terms of volume ofconsumption.Figure 12. Market share of generic medicines by value in France, 1994-2004Market share of generic medicines100%80%60%40%20%0%0,9%2,8% 3,9% 5,3% 6,6%0,8% 0,8% 0,8% 0,9% 1,2% 2,2%1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004YearFigure 13. Market share of generic medicines by volume in France, 1994-2004Market share of generic medicines100%80%60%40%20%0%9,1% 10,4%5,0%6,7%1,8% 1,6% 1,6% 1,6% 1,7% 2,2% 3,9%1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004Year
Page 4: Sustaining generic medicines market
Page 13: Sustaining generic medicines market
Page 16 and 17: Sustaining generic medicines market
Page 98 and 99:
Sustaining generic medicines market
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106:
Generic medicines create major savi
show all

Sustaining Generic Medicines Markets in Europe

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?